Yahoo Web Search

Sign In

Search results

  1. www.amgen.comAmgen | A Worldwide Pioneer in Biotechnology

    Jun 27, 2024 · Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

  2. www.bloomberg.com › quote › AMGN:USAMGN: Amgen Inc Stock Price Quote - NASDAQ GS - Bloomberg

    5 days ago · Stock analysis for Amgen Inc (AMGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  3. investors.amgen.com › node › 35461SEC Filing | Amgen Inc.

    Jun 12, 2024 · One Amgen Center Drive. Thousand Oaks, California : 91320-1799 (Address of Principal Executive Offices) (Zip Code)

  4. seekingalpha.com › article › 4702643-amgen-biotech-leaderAmgen: Biotech Leader Riding High On Obesity Drugs Euphoria...

    2 days ago · Amgen Inc. (NASDAQ:AMGN) is a high-quality biotech company with a well-diversified portfolio. Amgen has a solid pipeline focusing on five key therapeutic areas: Cancer, heart disease, osteoporosis ...

  5. www.amgen.com › stories › 2024Amgen Leaders Hail Southern California’s Emergence as Biotech ...

    Jun 11, 2024 · Three of Amgen’s top leaders hailed southern California’s growing reputation for biotech innovation and noted our company’s own contributions to it in remarks at the Los Angeles Bioscience Ecosystem Summit Twenty24, also known as LABEST 2024, which took place at the University of California Los Angeles on May 23, 2024.

  6. markets.businessinsider.com › news › stocksBuy Rating on Amgen: Promising Rocatinlimab Pipeline and Market...

    22 hours ago · Jul. 8, 2024, 06:15 AM. Michael Yee, an analyst from Jefferies, assigned the Buy rating on Amgen ( AMGN – Research Report ). The associated price target remains the same with $375.00. Michael ...

  7. seekingalpha.com › article › 4699629-amgen-you-havent-seenAmgen: You Haven't Seen Anything Yet - Seeking Alpha

    Jun 17, 2024 · Amgen is delighting investors with sales growth in its key blockbusters and the expansion of its portfolio of medications. Learn more on AMGN stock here.